Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $104.55 | 6 | 80.7% |
| Education | $24.99 | 1 | 19.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $46.95 | 2 | $0 (2019) |
| Merck Sharp & Dohme LLC | $31.32 | 2 | $0 (2024) |
| Allergan, Inc. | $19.09 | 1 | $0 (2020) |
| Gilead Sciences, Inc. | $17.55 | 1 | $0 (2024) |
| Shionogi Inc | $14.63 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $32.19 | 2 | Gilead Sciences, Inc. ($17.55) |
| 2022 | $14.63 | 1 | Shionogi Inc ($14.63) |
| 2020 | $19.09 | 1 | Allergan, Inc. ($19.09) |
| 2019 | $21.96 | 1 | Astellas Pharma US Inc ($21.96) |
| 2017 | $41.67 | 2 | Astellas Pharma US Inc ($24.99) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/24/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.55 | General |
| 10/20/2022 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Infections and Infectious Diseases | ||||||
| 02/07/2020 | Allergan, Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/06/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: ONCOLOGY | ||||||
| 10/04/2017 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $16.68 | General |
| 05/01/2017 | Astellas Pharma US Inc | — | Education | In-kind items and services | $24.99 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 67 | 97 | $28,227 | $6,624 |
| 2022 | 5 | 85 | 129 | $44,600 | $9,733 |
| 2021 | 3 | 51 | 89 | $30,512 | $6,582 |
| 2020 | 5 | 106 | 148 | $43,817 | $12,925 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 14 | 29 | $11,600 | $1,997 | 17.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 29 | $6,757 | $1,957 | 29.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $6,750 | $1,655 | 24.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 20 | 24 | $3,120 | $1,016 | 32.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 24 | 42 | $9,786 | $2,542 | 26.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $9,114 | $2,349 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 16 | 37 | $15,580 | $2,275 | 14.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 17 | $7,650 | $1,944 | 25.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 14 | 19 | $2,470 | $622.81 | 25.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 18 | 38 | $15,808 | $2,716 | 17.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 20 | 38 | $8,854 | $2,347 | 26.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 13 | 13 | $5,850 | $1,519 | 26.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 41 | 62 | $12,314 | $4,156 | 33.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 15 | 15 | $8,505 | $2,630 | 30.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 16 | 25 | $7,199 | $2,437 | 33.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 17 | 17 | $7,650 | $2,024 | 26.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 17 | 29 | $8,149 | $1,678 | 20.6% |
About Dr. Rose Kim, MD
Dr. Rose Kim, MD is a Infectious Disease healthcare provider based in Camden, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437175916.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rose Kim, MD has received a total of $129.54 in payments from pharmaceutical and medical device companies, with $32.19 received in 2024. These payments were reported across 7 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($104.55).
As a Medicare-enrolled provider, Kim has provided services to 309 Medicare beneficiaries, totaling 463 services with total Medicare billing of $35,865. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Location Camden, NJ
- Active Since 07/15/2006
- Last Updated 04/06/2021
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1437175916
Products in Payments
- XTANDI (Drug) $21.96
- AVYCAZ (Drug) $19.09
- PIFELTRO (Drug) $14.64
- Fetroja (Drug) $14.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Camden
Dr. Akinwale Olatosi, M.b.b.s, M.B.B.S
Infectious Disease — Payments: $41,876
Dr. Pola Dela Torre, Md, MD
Infectious Disease — Payments: $16,627
Dana Byrne, Md, MD
Infectious Disease — Payments: $1,885
Henry Fraimow, Md, MD
Infectious Disease — Payments: $1,513
Danielle Zambrano, Do, DO
Infectious Disease — Payments: $671.74
Lisa Pedroza, Md, MD
Infectious Disease — Payments: $650.52